 |
市场调查报告书
商品编码
1671871
成瘾治疗市场按类型、药物类型、分销管道和地区划分Addiction Treatment Market, By Type, By Drug Type, By Distribution Channel, By Geography |
||||||
价格
简介目录
2025 年全球成瘾治疗市场规模估计为 100.6 亿美元，预计到 2032 年将达到 149.4 亿美元，2025 年至 2032 年的复合年增长率为 5.8%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 100.6亿美元 |
| 效能资料 | 从 2020 年到 2024 年 | 预测期 | 2025 至 2032 年 |
| 预测期：2025-2032年复合年增长率： | 5.80% | 2032 年价值预测 | 149.4亿美元 |
数字。 2025 年成瘾治疗市场占有率（按地区划分）
成瘾是一种慢性健康状况，影响着全世界数百万人。它不仅对人们的身体造成影响，而且对人们的情感和经济也造成影响。成瘾很复杂，需要专门的治疗方法来促进復原。成瘾治疗市场包括广泛的服务，从排毒和康復到持续护理。神经科学的进步正在提高我们对成瘾的认识并影响治疗方法。治疗方法越来越多地针对同时发生的疾病以及成瘾的心理和社会方面。市场对基于证据的整体治疗方案的需求日益增长。
市场动态：
全球成瘾治疗市场的发展受到物质滥用障碍盛行率不断上升的推动，而这种障碍是由于人们容易获得成瘾物质而引起的。根据联合国统计，全球约有2.71亿人每年至少使用一次毒品。人们对有效治疗方法的认识不断提高，以及寻求帮助所带来的耻辱感不断减少，为行业相关人员创造了成长机会。然而，由于缺乏筛检和治疗基础设施以及社会障碍，开发中国家的市场潜力仍未充分开发。高昂的治疗费用也在一定程度上抑制了市场的成长。疫情期间，药物辅助治疗方法的接受度不断提高，远端医疗服务的扩展，可望使市场受益。
本研究的主要特点
- 本报告对全球成瘾治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
- 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
- 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
- 全球成瘾治疗市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
- 主要企业包括 Teva Pharmaceutical Industries Ltd.、Pfizer, Inc.、Alkremes Plc.、Glenmark Pharmaceuticals、GSK plc.、Johnson &Johnson Services, Inc.、Novartis AG、Perrigo Company plc.、Cipla、Dr. Reddy's Laboratories Limited、Hikma、Temputical Bio、BioCorRx Inc. 和 Opiant Pharmaceuticals Inc.
- 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球成瘾治疗市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过用于分析全球成瘾治疗市场的各种策略矩阵来促进决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 流行病学
- 市场趋势
- 主要进展
- 监管情景
- 製造商收益
- 收购和合作场景
- 产品发布/核准
- 资金筹措和投资
- PEST分析
- 波特的分析
4. 全球成瘾治疗市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 2020 年至 2032 年全球成瘾治疗市场（按类型）
- 酒精成瘾
- 烟草/尼古丁成瘾
- 阿片类药物成瘾
- 其他的
6. 2020 年至 2032 年按药物类型分類的全球成瘾治疗市场
- 阿片类药物
- Buprenornhine
- 美沙酮
- 纳曲酮
- 尼古丁替代疗法
- 尼古丁口香糖
- 尼古丁贴片
- 尼古丁含片
- 尼古丁喷雾
- 非尼古丁药物
- Varenicline
- 安非他酮
7. 2020 年至 2032 年按分销管道分類的全球成瘾治疗市场
- 2025 年及 2032 年市场占有率分析（%）
- 与前一年同期比较成长分析
- 细分趋势
- 医院药房
- 医疗用品商店
- 其他的
8. 2020 年至 2032 年全球成瘾治疗市场（按地区划分）
- 2025 年及 2032 年区域市场占有率分析（%）
- 与前一年同期比较
- 区域趋势
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲国家
- 欧洲
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第九章 竞争格局
- 公司简介
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Alkremes Plc.
- Glenmark Pharmaceuticals
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Dr. Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan NV
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
第 10 章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会地图
第 11 章 参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI4853
Global Addiction Treatment Market is estimated to be valued at USD 10.06 Bn in 2025 and is expected to reach USD 14.94 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 10.06 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.80% | 2032 Value Projection: | USD 14.94 Bn |
Figure. Addiction Treatment Market Share (%), By Region 2025
Addiction is a chronic health condition that affects millions globally. It impacts individuals physically as well as emotionally and economically. The complexity of addiction demands professional treatment approaches to facilitate recovery. The addiction treatment market encompasses a wide range of services from detoxification and rehabilitation to continuing care. Advancements in neuroscience have deepened the understanding of addiction and influenced treatment modalities. Therapies are becoming increasingly tailored to address co-occurring disorders as well as the psychological and social aspects of addiction. The market is witnessing rising demand for evidence-based and holistic treatment options.
Market Dynamics:
The global addiction treatment market is driven by the rising prevalence of substance abuse disorders fueled by easy access to addictive substances. According to the United Nations, around 271 million people globally use drugs at least once a year. Increasing awareness about effective treatment options and reduced stigma associated with seeking help are creating growth opportunities for industry players. However, the market potential remains relatively untapped in developing nations due to lack of screening and treatment infrastructure as well as social barriers. High treatment costs also restrain the market growth to some extent. The market is poised to gain from the growing acceptance of medication-assisted treatment approaches and expansion of telehealth offerings during the pandemic.
Key Features of the Study:
- This report provides an in-depth analysis of the global addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this includes Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Alkremes Plc., Glenmark Pharmaceuticals, GSK plc, Johnson & Johnson Services, Inc., Novartis AG, Perrigo Company plc., Cipla , Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., Eli Lilly and Company, Tempero Bio, BioCorRx Inc., and Opiant Pharmaceuticals Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global addiction treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global addiction treatment market
Detailed Segmentation-
- By Type:
- Alcohol Addiction
- Tobacco/Nicotine Addiction
- Opioid Addiction
- Others
- By Drug Type:
- Opioids
- Buprenorphine
- Methadone
- Naltrexone
- Nicotine Replacement Therapies
- Nicotine Gums
- Nicotine Patches
- Nicotine Lozenges
- Nicotine Spray
- Non-Nicotine Medication
- Varenicline
- Bupropion
- By Distribution Channel:
- Hospital Pharmacies
- Medical Stores
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Alkremes Plc.
- Glenmark Pharmaceuticals
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Epidemiology
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Addiction Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Addiction Treatment Market, By Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Alcohol Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tobbacco/Nicotine Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Opioid Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Addiction Treatment Market, By Drug Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Opioids
- Buprenorphine
- Methadone
- Naltrexone
- Nicotine Replacement Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nicotine Gums
- Nicotine Patches
- Nicotine Lozenges
- Nicotine Spray
- Non-Nicotine Medication
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Varenicline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bupropion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Addiction Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Addiction Treatment Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alkremes Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Dr. Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
